Novartis AG (NVS)
NYSE·Healthcare·Drug Manufacturers - General
$160.74
-0.25%
Mkt Cap $314.69B
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$170.00
Range $170.00 – $170.00
Implied Upside
+5.8%
Consensus $170.00 vs current $160.74
NYSE·Healthcare·Drug Manufacturers - General
$160.74
-0.25%
Mkt Cap $314.69B
No recent rating data.
Price Target (8 analysts)
$170.00
Range $170.00 – $170.00
+5.8%
Consensus $170.00 vs current $160.74